NIH-funded discovery uses common antifungal drug to improve lungs’ ability to fight infection Researchers say a widely-used antifungal drug may hold promise for treating people with cystic fibrosis, a life-threatening genetic disorder that causes serious damage to the lungs. In studies using human cells and animals models, the researchers found...
Researchers have optimized CRISPR-Cas9 technology, a gene editing approach revolutionizing medical research, to achieve therapeutic editing of the blood stem cell population.
Researchers have developed bioengineered blood vessels that closely mimic the structure and function of human blood vessels and show promise of being safer and more effective than current grafts made of synthetic materials.
Researchers are reporting in animal studies that using a certain drug to target cystic fibrosis (CF) in the womb could prevent damage to organs, including the pancreas and lungs. CF is a life-threatening, multiorgan genetic disorder that causes serious damage to the lungs.
Researchers are reporting that drinking sugary beverages like sodas and sports drinks is associated with a greater risk of death from heart disease, especially among women.
An NHLBI-funded study found that the higher the consumption of dietary cholesterol or eggs, the higher the incidence of cardiovascular disease, which includes heart disease and stroke, and death from any cause among U.S. adults.
Compared to drug therapies, catheter ablation, a common cardiovascular procedure, didn’t achieve a significant reduction of strokes, deaths, and other complications in patients with atrial fibrillation.
Women 60 and older can see significant improvements in their heart health from even light physical activity, such as housework, gardening, and leisurely strolls.
Researchers have confirmed that a non-invasive imaging method called parametric response mapping can detect small airway damage in chronic obstructive pulmonary disease, or COPD, on a chest CT scan.
Jennelle Stephenson, 28, who was born with sickle cell disease, shared her experience of recovery after receiving genetic treatment as part of an NIH clinical trial that might hold the key to a cure of this disease.
Permitting first-year doctors to work longer shifts does not create chronic sleep loss or reduce patient safety, according to the results of two large national studies.